• 主题
高级搜索  >
历史搜索 清空历史
首页> 中文期刊> 《肿瘤学与转化医学（英文）》 >Is EGFR gene mutation testing necessary in smokers with non-small cell lung cancer?

Is EGFR gene mutation testing necessary in smokers with non-small cell lung cancer?

         
页面导航
  • 摘要
  • 著录项
  • 相关主题

摘要

Objective Previous studies have proven that cumulative smoking dose predicts the prevalence of epidermal growth factor receptor (EGFR) mutations. The aim of this study was to investigate the relationship between smoking-related factors and EGFR mutation status.Methods Samples were collected from 195 smokers with non-small cell lung cancer (NSCLC) who underwent surgical resection and the presence of EGFR mutations (exons 19 and 21) were determined by real-time polymerase chain reaction (RT-PCR).Results EGFR gene mutations were present in 33 (16.9%) patients who were smokers; the patients were divided into three groups according to the smoking index (SI). The incidence of EGFR mutations decreased from 38.9% in mild smokers to 8.1% in severe smokers (P = 0.001). Compared to daily smoking dose (P= 0.547), initial smoking age (P = 0.085) and duration of smoking history had a larger effect on EGFR mutation status (P = 0.002).Conclusion Although there is a decrease in the incidence of mutations with increasing SI, there were still around 17% of smokers with NSCLC that harbored EGFR mutations, so it is necessary to test for EGFR mutation status in smokers with NSCLC.

著录项

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号